Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Transplantation and Cellular Therapy
|
February 16, 2022
A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors
Folashade Otegbeye, Brenda Cooper, Paolo Caimi, et al.
Immunity
|
April 3, 2007
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis
Hui Xiao, Muhammet Fatih Gulen, Jinzhong Qin, et al.
Frontiers in Immunology
|
February 5, 2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024
Gisela Maria Suárez Formigo, Zaima Mazorra, Cinthia Olexen, et al.
Haematologica
|
November 7, 2024
Arsenic trioxide <i>versus</i> Realgar-Indigo naturalis formula in non-high-risk acute promyelocytic leukemia: a multicenter, randomized trial
Shu Chen, Weiwei Qin, Xiaohong Lu, et al.
Molecular Cancer
|
May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square
|
May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
The Journal of Clinical Investigation
|
July 18, 2018
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
Xiaorong Gu, Quteba Ebrahem, Reda Z Mahfouz, et al.
Haematologica
|
May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy
Chiara Tarantelli, David Wald, Nicolas Munz, et al.
Transplantation and Cellular Therapy
|
July 10, 2024
An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil
Caroline Mitiká Watanabe, Caroline Ishihama Suzuki, Alessandro Marins Dos Santos, et al.
Nature Communications
|
December 11, 2021
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
Michael Maschan, Paolo F Caimi, Jane Reese-Koc, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Transplantation and Cellular Therapy
|
February 16, 2022
A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors
Folashade Otegbeye, Brenda Cooper, Paolo Caimi, et al.
Immunity
|
April 3, 2007
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis
Hui Xiao, Muhammet Fatih Gulen, Jinzhong Qin, et al.
Frontiers in Immunology
|
February 5, 2026
Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024
Gisela Maria Suárez Formigo, Zaima Mazorra, Cinthia Olexen, et al.
Haematologica
|
November 7, 2024
Arsenic trioxide <i>versus</i> Realgar-Indigo naturalis formula in non-high-risk acute promyelocytic leukemia: a multicenter, randomized trial
Shu Chen, Weiwei Qin, Xiaohong Lu, et al.
Molecular Cancer
|
May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square
|
May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
The Journal of Clinical Investigation
|
July 18, 2018
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
Xiaorong Gu, Quteba Ebrahem, Reda Z Mahfouz, et al.
Haematologica
|
May 9, 2024
Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy
Chiara Tarantelli, David Wald, Nicolas Munz, et al.
Transplantation and Cellular Therapy
|
July 10, 2024
An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil
Caroline Mitiká Watanabe, Caroline Ishihama Suzuki, Alessandro Marins Dos Santos, et al.
Nature Communications
|
December 11, 2021
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients
Michael Maschan, Paolo F Caimi, Jane Reese-Koc, et al.
Page
of 6